Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
25 Leser
Artikel bewerten:
(0)

Bode Technology Reaches Sales Milestone of DNA Collectors

LORTON, Va., July 31, 2013 /PRNewswire/ --The Bode Technology Group, Inc. (Bode), a leading provider of forensic DNA products and services, announced it has reached significant milestones in sales of its two patented DNA collection systems. The company has sold over 5,000,000 Buccal DNA Collector' and SecurSwab' evidence collection products. Bode's innovative DNA collection systems are designed to improve the efficiency, reliability, and security of the collection and processing of evidence and biological samples from individuals and crime scenes.

"As a forensic DNA crime laboratory, we know that the quality and integrity of DNA evidence can make-or-break solving a case. Reliable collection devices not only improve the chances of obtaining a DNA profile, but also enable efficiency in the laboratory," said Mike Cariola, CEO and President of Bode. "In today's financial environment, streamlined lab operations are critical to the success of a forensic DNA crime lab."

Bode's DNA collection systems have been adopted worldwide for use in DNA databasing programs, most recentlyin Southeast Asia and for casework programs at Los Angeles Sheriff's Department andthe New York Police Department. These innovative and proprietary collection devices are shown to improve DNA collection. Recently, the National Forensic Science Technology Center (NFSTC) published a study showing the SecurSwab DUO-V had the best DNA recovery of all swabs evaluated. It collected the most DNA and has features that prevent contamination and reduces possible degradation.

A company White Paper evaluating the efficiency of the Bode Buccal DNA Collector proves that use of the direct collection system reduces cost, processing time, re-run and re-collection rates, saving money for crime laboratories.

"Bode continues to seek improvement in DNA technologies, from collection devices through processing methods in the laboratory. When developing collection products, we create a system that includes collection, chain-of-custody control, sample protection and sample storage. These elements help law enforcement officers and DNA analysts obtain results that can be used to solve crimes," said Andrew Singer, Sr. Product Manager at Bode. "We do all of this with the highest standards used in the forensic industry."

Bode's collection products are manufactured in an FDA registered facility under cGMP guidelines and clean room conditions. All DNA collection products are certified to be free of human DNA and DNase.

About The Bode Technology Group, Inc.

Bode Technology provides a comprehensive set of state-of-the-art forensic DNA collection products, analysis services, and research services to law enforcement, justice system, and other government agencies around the world. Operating one of the most internationally respected private DNA laboratories, Bode's forensic DNA experts have assisted in identifying criminals in every state in the United States, and played a key role in the exoneration of numerous individuals. Bode provides immigration and paternity testing worldwide. Bode has also been instrumental in the identification of victims of natural disasters, war, crime, and terrorism, including the attack on the World Trade Center.

Bode Technology is one of the three wholly owned subsidiaries of SolutionPoint International, Inc. (www.solutionpoint-intl.com), a leading provider of business intelligence, security, compliance and monitoring, identity assurance, forensics, and situational awareness solutions for the commercial and government sectors. Through the dedicated focus on excellence of its management teams and employees, SolutionPoint enables its clients to achieve their objectives with the confidence that they can operate in a secure and trusted environment. SolutionPoint is headquartered in New York, NY, and maintains offices and facilities in Washington, D.C.; San Diego, CA; Dallas, TX; Oakland, CA; San Francisco, CA; Chicago, IL; and Lorton, VA. SolutionPoint also operates internationally with an office in London, United Kingdom and a recently opened office in Riyadh, Saudi Arabia.

SOURCE The Bode Technology Group, Inc.

© 2013 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.